skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: A new Os-191->Ir-191m generator for radionuclide angiocardiography

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6794831

Ultrashort-lived radionuclides offer several advantages in angiocardiography in comparison to Tc-99m. Of the isotopes proposed for this application, I-191m (T/sub 1/2/=5 s) has several advantages when compared to Au-195m (T/sub 1/2/=30.5 s) (longer generator shelf-life) and Ag-109m (T/sub 1/2/= 40 s) (higher photon yield). The Ir-191m generator currently in clinical use suffers, however, from low Ir-191m yield (10% ml) and relatively high breakthrough of the Os-191 parent (5 x 10/sup -3/%/ml). The authors have recently developed a new Ir-191m generator that offers higher yield (20-30%/ml) and lower breakthrough (5 x 10/sup -4/%/ml) using an eluent that is only slightly hypertonic and does not require buffering prior to injection. A biodistribution study in mice shows the Os-191 breakthrough products, which are responsible for 80% of the patient radiation dose, to be cleared from the body more quickly than those of the earlier generator. This combination of 2-3 times higher yield, ten times lower breakthrough, and more rapid excretion results in a 30-50 fold decrease in the patient absorbed dose per study when compared to the earlier design. An additional advantage is the absence of a ''scavenger'' column. More than 200 radionuclide angiograms have been recorded in dogs with no adverse reactions and preliminary studies in mice have revealed no toxic effects attributable to the eluate.

Research Organization:
The Children's Hospital and Harvard Medical School, Boston, MA
OSTI ID:
6794831
Report Number(s):
CONF-850611-; TRN: 87-010700
Journal Information:
J. Nucl. Med.; (United States), Vol. 26:5; Conference: 32. annual meeting of the Society of Nuclear Medicine, Houston, TX, USA, 2 Jun 1985
Country of Publication:
United States
Language:
English